Geneva hospital reviews 'Magic Mushroom' and LSD therapy for depression
NCT ID NCT07164287
Summary
This study is looking back at medical records to understand how supervised therapy using substances like LSD or psilocybin (from 'magic mushrooms') worked for people with severe depression, anxiety, or addiction. It involves about 376 people in Switzerland who had already received this special treatment because other standard treatments failed. The main goal is to see if the strength of the psychedelic experience is linked to how much their symptoms improved.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Geneva University Hospital
Geneva, Switzerland
Conditions
Explore the condition pages connected to this study.